Table 3.
Results lymphoedema and tissue induration
| Group mean ± SD b-8 | Between group changes 0-8 | Group mean ± SD 8b-12 | Between group changes 8b-12 | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
Variable Gp(n) |
Week 0 M ± SD |
Week 8 M ± SD |
∆int-∆con 0–8 MD; (95% Cl) |
P(0–8) |
Variable Gp(n) |
Week 8b M ± SD |
Week 12 m ± SD |
∆int-∆con 8b-12 MD; (95% CI) |
P(8b-12) |
|
Lymphoedema L-dex (BIS) | |||||||||
| Con (11) |
6.49 ± 14.14 |
7.66 ± 12.64 |
-1.03; (-4.17 to 2.10) |
0.519 |
Con(10) |
8.68 ± 12.83 |
7.83 ± 13.59 |
2.57; (-1.04 to 6.18) |
0.163 |
| Int(12) |
5.89 ± 9.07 |
6.03 ± 8.24 |
Int(9) |
4.96 ± 6.40 |
6.67 ± 7.08 |
|
|||
| Arm volume | |||||||||
| Con(11) |
59.89 ± 78.53 |
60.75 ± 80.69 |
-30.28; (-69.33 to 8.78) |
0.129 |
Con(10) |
67.65 ± 82.39 |
58.17 ± 100.42 |
35.20; (3.09 to 67.32) |
0.032 |
| Int(12) |
101.45 ± 75.08 |
72.03 ± 80.77 |
Int(9) |
60.82 ± 82.84 |
86.53 ± 78.29 |
|
|||
|
Tissue induration (Tonometry) Forearm affected | |||||||||
| Con(11) |
13.96 ± 3.82 |
14.06 ± 4.80 |
0-1.89; (-4.88 to 1.16) |
0.227 |
Con(10) |
13.65 ± 4.85 |
12.45 ± 4.36 |
-0.43; (-2.77 to 1.92) |
0.42 |
| Int(12) |
15.78 ± 4.79 |
14.02 ± 3.59 |
Int(9) |
13.87 ± 3.68 |
12.26 ± 2.41 |
||||
| Forearm non-affected | |||||||||
| Con(11) |
15.61 ± 4.17 |
15.81 ± 5.20 |
-140; (-4.59 to 1.78) |
0.387 |
Con(10) |
15.37 ± 5.27 |
12.66 ± 4.00 |
0.10; (-3.09 to 3.30) |
0.95 |
| Int(12) |
15.92 ± 5.51 |
14.72 ± 5.42 |
|
Int(9) |
14.68 ± 6.23 |
12.07 ± 4028 |
|||
| Upper arm affected | |||||||||
| Con(11) |
10.66 ± 5.57 |
12.54 ± 5.91 |
-3.20; (-641 to 0) |
0.050 |
Con(9) |
12.08 ± 6.02 |
8.92 ± 5.19 |
0.95; (-1.40 to 3.30) |
0.43 |
| Int(12) |
11.10 ± 6.09 |
9.77 ± 3.33 |
Int(9) |
9.63 ± 3.53 |
7.42 ± 4.39 |
||||
| Upper arm non-affected | |||||||||
| Con(10) |
10.14 ± 4.42 |
12.05 ± 6026 |
-2.88; (-5.82 to 0.06) |
0.055 |
Con(10) |
11.46 ± 6.34 |
7.97 ± 5.18 |
0.53; (-1.98 to 3.03) |
0.68 |
| Int(12) |
9.88 ± 4.09 |
8.91 ± 3.621 |
Int(9) |
8.17 ± 3.54 |
5.21 ± 3.10 |
||||
| Chest affected | |||||||||
| Con(11) |
6.78 ± 2.39 |
5.53 ± 3.41 |
-0.36; (-2.63 to 1.91) |
0.758 |
Cont(10Int(9) |
5.22 ± 3.43 |
5.76 ± 1.50 |
-0.60; (-2.94 to 1.73) |
0.61 |
| Int(12) |
6.34 ± 2.01 |
4.73 ± 1.75 |
|
4.23 ± 1.14 |
4.17 ± 1.09 |
||||
| Chest non-affected | |||||||||
| Con(11) |
5.59 ± 1.84 |
4.76 ± 2.65 |
-0.34; (-2.85 to 2.17) |
0.878† |
Con(10) |
4.70 ± 2.79 |
6.18 ± 5.00 |
-1.22; (-5.33 to 2.90) |
0.56 |
| Int(12) |
6.06 ± 1.87 |
4.90 ± 1.97 |
Int(9) |
4.98 ± 2.23 |
5.25 ± 1.60 |
||||
| Upper back affected | |||||||||
| Con(11) |
16.17 ± 2.39 |
16.76 ± 4.32 |
0.19; (-3.77 to 4.16) |
0.924 |
Con(10) |
16.48 ± 4.45 |
13.21 ± 5.06 |
1.10; (-1.51 to 3.70) |
0.41 |
| Int(12) |
16.06 ± 4.18 |
16.84 ± 4.82 |
Int(9) |
15.81 ± 4.28 |
13.63 ± 2.930 |
||||
| Upper back non-affected | |||||||||
| Con(11) |
14.32 ± 3.87 |
15.13 ± 5.54 |
-1.42; (-4.85 to 2.02) | 0.419 | Con(10) |
15.04 ± 5.79 |
14.43 ± 4.32 |
-0.48; (-3.90 to 2.95) | 0.78 |
| Int(12) | 15.55 ± 4.21 | 15.05 ± 4.86 | Int(9) | 14.66 ± 5.33 | 13.58 ± 3.83 | ||||
∆ = change; Gp = Group; M ± SD = Mean ± Standard Deviation; MD = Mean Difference; CI = Confidence Interval.
n = number.
Con = control group; Int = intervention group.
† = non-parametic analysis; b = week 0.